Basic Information
RNALocate ID: | RLID:11000732 |
RNA Symbol: | hsa-miR-19b-3p |
Localization: | Extracellular Vesicle |
RNA Information
RNA Name: | hsa-miR-19b-3p |
RNA ID: | miRBase:MIMAT0000074 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 28588009 |
Tissue/Cell Line: | Liposarcoma cell lines (Lipo246|Lipo863|LPS141)|Preadipocytes |
Method: | NanoString nCounter assay |
Condition: | Liposarcoma|Healthy |
Heat map representation of the top deregulated miRNAs in LPS-PBVs. Originally published in Cancer Res. Casadei L, et al, 2017. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | To determine which miRNAs were secreted from LPS cells and elucidate their possible role as prognostic “signatures,” we performed a NanoString profiling on RNA samples isolated from peripheral blood plasma Vesicles (PBVs) derived from 16 human LPS patient samples and from 8 healthy controls Supplementary Table S1. Figure 1A depicts a heatmap of the most differentially expressed PBVs miRNAs (102 miRNAs). Data are collected from Figure 1A. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001283 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001284 | Cytoplasm | Colon cancer cells | 20864815 |
RLID:01001285 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001286 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001287 | Mitochondrion | Myotube | 27396686 |
RLID:01001288 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001289 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001290 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001291 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001292 | Nucleus | GC cell line (MGC-803) | 29872807 |
RLID:01001293 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11000724 | Exosome | Glioblastoma cells | 19011622 |
RLID:11000725 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000726 | Exosome | Renal cancer cells | 21670082 |
RLID:11000727 | Exosome | Brain tissue | 23382797 |
RLID:11000728 | Exosome | Plasma | 23663360 |
RLID:11000729 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000730 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11000731 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11000733 | Microvesicle | Glioblastoma cells | 19011622 |
RLID:11000734 | Microvesicle | Seminal plasma | 23539611 |
RLID:11000735 | Microvesicle | Follicular fluid | 23666971 |
RLID:11000736 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000011 | Exosome | B lymphoblastoid cells|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000273 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-19b-3p | Diffuse large b cell lymphoma | MNDR-E-MI-25628 |
MNDR | hsa-miR-19b-3p | Mantle cell lymphoma | MNDR-E-MI-25629 |
MNDR | hsa-miR-19b-3p | Splenic marginal zone lymphoma | MNDR-E-MI-25630 |
MNDR | hsa-miR-19b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-25631 |
MNDR | hsa-miR-19b-3p | Oral squamous cell carcinoma | MNDR-E-MI-25632 |
MNDR | hsa-miR-19b-3p | Large cell neuroendocrine cancer | MNDR-E-MI-25633 |
MNDR | hsa-miR-19b-3p | Medulloblastoma | MNDR-E-MI-25634 |
MNDR | hsa-miR-19b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-25635 |
MNDR | hsa-miR-19b-3p | Lymphoma | MNDR-E-MI-25636 |
MNDR | hsa-miR-19b-3p | Lymphoma non-hodgkin | MNDR-E-MI-25637 |
MNDR | hsa-miR-19b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-25638 |
MNDR | hsa-miR-19b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-25639 |
MNDR | hsa-miR-19b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-25640 |
MNDR | hsa-miR-19b-3p | Niemann-pick disease type c | MNDR-E-MI-25641 |
MNDR | hsa-miR-19b-3p | Prostate cancer | MNDR-E-MI-25642 |
MNDR | hsa-miR-19b-3p | Gastric cancer | MNDR-E-MI-25643 |
MNDR | hsa-miR-19b-3p | Gastric lymphoma | MNDR-E-MI-25644 |
MNDR | hsa-miR-19b-3p | Alzheimer disease | MNDR-E-MI-25645 |
MNDR | hsa-miR-19b-3p | Encephalitis japanese | MNDR-E-MI-25646 |
MNDR | hsa-miR-19b-3p | Intracranial aneurysm | MNDR-E-MI-25647 |
MNDR | hsa-miR-19b-3p | Bladder cancer | MNDR-E-MI-25648 |
MNDR | hsa-miR-19b-3p | Sarcoma | MNDR-E-MI-25649 |
MNDR | hsa-miR-19b-3p | Dysautonomia familial | MNDR-E-MI-25650 |
MNDR | hsa-miR-19b-3p | Head and neck cancer | MNDR-E-MI-25651 |
MNDR | hsa-miR-19b-3p | Huntington disease | MNDR-E-MI-25652 |
MNDR | hsa-miR-19b-3p | Chorea | MNDR-E-MI-25653 |
MNDR | hsa-miR-19b-3p | Cardiovascular disease | MNDR-E-MI-25654 |
MNDR | hsa-miR-19b-3p | Carotid stenosis | MNDR-E-MI-25655 |
MNDR | hsa-miR-19b-3p | Moyamoya disease | MNDR-E-MI-25656 |
MNDR | hsa-miR-19b-3p | Lung cancer | MNDR-E-MI-25657 |
MNDR | hsa-miR-19b-3p | Fragile x syndrome | MNDR-E-MI-25658 |
MNDR | hsa-miR-19b-3p | Parkinson disease | MNDR-E-MI-25659 |
MNDR | hsa-miR-19b-3p | Machado-joseph disease | MNDR-E-MI-25660 |
MNDR | hsa-miR-19b-3p | Niemann-pick disease | MNDR-E-MI-25661 |
MNDR | hsa-miR-19b-3p | Basal-like breast cancer | MNDR-E-MI-25662 |
MNDR | hsa-miR-19b-3p | Squamous cell carcinoma | MNDR-E-MI-25663 |
MNDR | hsa-miR-19b-3p | Thyroid cancer | MNDR-E-MI-25664 |
MNDR | hsa-miR-19b-3p | Pancreatic cancer | MNDR-E-MI-25665 |
MNDR | hsa-miR-19b-3p | Malignant melanoma | MNDR-E-MI-25666 |
MNDR | hsa-miR-19b-3p | Atherosclerosis | MNDR-E-MI-25667 |
MNDR | hsa-miR-19b-3p | Rectum adenocarcinoma | MNDR-E-MI-25668 |
MNDR | hsa-miR-19b-3p | Nephroblastoma | MNDR-E-MI-25669 |
MNDR | hsa-miR-19b-3p | Colon cancer | MNDR-E-MI-25670 |
MNDR | hsa-miR-19b-3p | Ischemic attack transient | MNDR-E-MI-25671 |
MNDR | hsa-miR-19b-3p | Colon adenocarcinoma | MNDR-E-MI-25672 |
MNDR | hsa-miR-19b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-25673 |
MNDR | hsa-miR-19b-3p | Familial ovarian cancer | MNDR-E-MI-25674 |
MNDR | hsa-miR-19b-3p | Basal cell carcinoma | MNDR-E-MI-25675 |
MNDR | hsa-miR-19b-3p | Prostate adenocarcinoma | MNDR-E-MI-25676 |
MNDR | hsa-miR-19b-3p | Kidney cancer | MNDR-E-MI-25677 |
MNDR | hsa-miR-19b-3p | Thyroid adenomas | MNDR-E-MI-25678 |
MNDR | hsa-miR-19b-3p | Carcinoma ductal breast | MNDR-E-MI-25679 |
MNDR | hsa-miR-19b-3p | Glioblastoma | MNDR-E-MI-25680 |
MNDR | hsa-miR-19b-3p | Astrocytoma | MNDR-E-MI-25681 |
MNDR | hsa-miR-19b-3p | Glioma | MNDR-E-MI-25682 |
MNDR | hsa-miR-19b-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-25683 |
MNDR | hsa-miR-19b-3p | Central nervous system lymphoma | MNDR-E-MI-25684 |
MNDR | hsa-miR-19b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-25685 |
MNDR | hsa-miR-19b-3p | Osteosarcoma | MNDR-E-MI-25686 |
MNDR | hsa-miR-19b-3p | Liposarcoma | MNDR-E-MI-25687 |
MNDR | hsa-miR-19b-3p | Coronary artery disease | MNDR-E-MI-25688 |
MNDR | hsa-miR-19b-3p | Meningioma | MNDR-E-MI-25689 |
MNDR | hsa-miR-19b-3p | Liver cancer | MNDR-E-MI-25690 |
MNDR | hsa-miR-19b-3p | Cervical adenocarcinoma | MNDR-E-MI-25691 |
MNDR | hsa-miR-19b-3p | Gastric adenocarcinoma | MNDR-E-MI-25692 |
MNDR | hsa-miR-19b-3p | Cervical squamous cell carcinoma | MNDR-E-MI-25693 |
MNDR | hsa-miR-19b-3p | Lung squamous cell carcinoma | MNDR-E-MI-25694 |
MNDR | hsa-miR-19b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-25695 |
MNDR | hsa-miR-19b-3p | Lung adenocarcinoma | MNDR-E-MI-25696 |
MNDR | hsa-miR-19b-3p | Thyroid carcinoma | MNDR-E-MI-25697 |
MNDR | hsa-miR-19b-3p | Bladder urothelial carcinoma | MNDR-E-MI-25698 |
MNDR | hsa-miR-19b-3p | Cervical cancer | MNDR-E-MI-25699 |
MNDR | hsa-miR-19b-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-25700 |
MNDR | hsa-miR-19b-3p | Carcinoma renal cell | MNDR-E-MI-25701 |
MNDR | hsa-miR-19b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-25702 |
MNDR | hsa-miR-19b-3p | Renal clear cell carcinoma | MNDR-E-MI-25703 |
MNDR | hsa-miR-19b-3p | Biliary tract cancer | MNDR-E-MI-25704 |
MNDR | hsa-miR-19b-3p | Cholangiocarcinoma | MNDR-E-MI-25705 |
MNDR | hsa-miR-19b-3p | Esophageal cancer | MNDR-E-MI-25706 |
MNDR | hsa-miR-19b-3p | Lung small cell carcinoma | MNDR-E-MI-25707 |
MNDR | hsa-miR-19b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-25708 |
MNDR | hsa-miR-19b-3p | Encephalomyelitis | MNDR-E-MI-25709 |
MNDR | hsa-miR-19b-3p | Breast invasive carcinoma | MNDR-E-MI-25710 |
MNDR | hsa-miR-19b-3p | Hepatocellular carcinoma | MNDR-E-MI-25711 |
MNDR | hsa-miR-19b-3p | Familiar ovarian carcinoma | MNDR-E-MI-25712 |
MNDR | hsa-miR-19b-3p | B-cell lymphoma | MNDR-E-MI-25713 |
MNDR | hsa-miR-19b-3p | Rheumatoid arthritis | MNDR-E-MI-25714 |
MNDR | hsa-miR-19b-3p | T-cell leukemia | MNDR-E-MI-25715 |
MNDR | hsa-miR-19b-3p | Cervical carcinoma | MNDR-E-MI-25716 |
MNDR | hsa-miR-19b-3p | Retinoblastoma | MNDR-E-MI-25717 |
MNDR | hsa-miR-19b-3p | Neuroblastoma | MNDR-E-MI-25718 |
MNDR | hsa-miR-19b-3p | Hodgkin lymphoma | MNDR-E-MI-25719 |
MNDR | hsa-miR-19b-3p | Burkitt lymphoma | MNDR-E-MI-25720 |
MNDR | hsa-miR-19b-3p | Lymphosarcoma | MNDR-E-MI-25721 |
MNDR | hsa-miR-19b-3p | Crohn disease | MNDR-E-MI-25722 |
MNDR | hsa-miR-19b-3p | Intermediate coronary syndrome | MNDR-E-MI-25723 |
MNDR | hsa-miR-19b-3p | Tonsil cancer | MNDR-E-MI-25724 |
MNDR | hsa-miR-19b-3p | Acute myelogenous leukemia | MNDR-E-MI-25725 |
MNDR | hsa-miR-19b-3p | Colorectal cancer | MNDR-E-MI-25726 |
MNDR | hsa-miR-19b-3p | Nasopharyngeal carcinoma | MNDR-E-MI-25727 |
MNDR | hsa-miR-19b-3p | Nasopharynx carcinoma | MNDR-E-MI-25728 |
MNDR | hsa-miR-19b-3p | Multiple myeloma | MNDR-E-MI-25729 |
MNDR | hsa-miR-19b-3p | Carcinoid tumors intestinal | MNDR-E-MI-25730 |
MNDR | hsa-miR-19b-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-25731 |
MNDR | hsa-miR-19b-3p | Uterine cervical neoplasms | MNDR-E-MI-25732 |
MNDR | hsa-miR-19b-3p | Ependymoma | MNDR-E-MI-25733 |
MNDR | hsa-miR-19b-3p | Nasopharyngeal cancer | MNDR-E-MI-25734 |
MNDR | hsa-miR-19b-3p | Prostatic neoplasms | MNDR-E-MI-25735 |
MNDR | hsa-miR-19b-3p | Stroke lacunar | MNDR-E-MI-25736 |
MNDR | hsa-miR-19b-3p | Duke A | MNDR-E-MI-25737 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022778 |
TOP